Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
4
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
nivolumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
What
companies
4
×
new
4
×
drug
ipo
medicines
therapeutics
addition
alltrna
announced
approval
based
betting
bio
biogen’s
biopharmaceutical
biotech
biotechs
black
called
cancer
clinic
club
company
continued
convo
crop
curious
developing
diamond
diseases
earlier
eluded
exceeded
failures
firms
flagship
focus
following
group
haul
Language
unset
Current search:
companies
×
cancer
×
new
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
